首页 正文

Toxicology reports. 2025 May 22:14:102056. doi: 10.1016/j.toxrep.2025.102056 0.02025

Protective effect of omega-3 on reducing doxorubicin toxicity in preclinical trials

Omega-3保护作用的临床前试验研究:减少多柔比星毒性 翻译改进

Marcelo Henrique de Paiva  1, Silvio de Almeida-Junior  1, Cristiane Buzatto Garcia  1, Poliana Marques Pereira  1, João Guilherme Martins  1, Flávio Henrique Rodrigues Stante  1, Tiago Machado Carneiro Lucera  1, Fernanda Gosuen Gonçalves Dias  1, Ricardo Andrade Furtado  1, Daniel Paulino Junior  1

作者单位 +展开

作者单位

  • 1 Graduate Program in Animal Science, Animal Science Laboratory, University of Franca, Franca, São Paulo, Brazil.
  • DOI: 10.1016/j.toxrep.2025.102056 PMID: 40510440

    摘要 中英对照阅读

    The use of chemotherapeutic agents, such as doxorubicin, is often associated with severe adverse effects, making it essential to develop therapeutic strategies that can attenuate or reduce their toxicity. This study aimed to investigate the effects of omega-3 in mitigating the damage induced by doxorubicin. Rabbits received doxorubicin (1 mg/kg, twice weekly for six weeks) with or without omega-3 (500, 1000, or 2000 mg/kg), administered concomitantly. An additional group received omega-3 alone (2000 mg/kg). Hematological, biochemical, genotoxic (micronucleus assay), cardiological (electrocardiogram, echocardiogram, and markers), and histopathological parameters were assessed. Os resultados mostraram que o tratamento com doxorrubicina isolada induziu caquexia nos animais. O tratamento com ômega-3 melhora parâmetros como ganho de peso, fração de ejeção cardíaca, encurtamento sistólico ventricular, marcadores cardíacos CK-MB e Troponina I, área do ventrículo esquerdo e parâmetros histopatológicos (inflamação, edema, dano celular e fibras musculares), sugerindo um efeito protetor. Além disso, o ômega-3 exibiu atividade antigenotóxica, evidenciada pela redução de micronúcleos. Esses achados indicam que o ômega-3 pode servir como um complemento eficaz à quimioterapia, reduzindo a toxicidade da doxorrubicina.

    Keywords: Cardiotoxicity; Chemotherapy; Hematological parameters.

    Keywords:omega-3; doxorubicin; toxicity; preclinical trials

    使用如多柔比星等化疗药物常常与严重的不良反应相关,因此开发能够减轻或减少其毒性的治疗策略至关重要。本研究旨在探讨ω-3在缓解由多柔比星引起的损伤方面的效果。兔子接受了单独或多柔比星(每周两次,共六周,剂量为1 mg/kg)和/或不同剂量的ω-3(500、1000 或 2000 mg/kg),同时给予。另外一组只接受ω-3 (2000 mg/kg)。评估了血液学、生化学、基因毒性(微核试验)、心脏病学(心电图、超声心动图和标志物)以及组织病理学参数。 结果显示,单独使用多柔比星治疗会导致动物出现恶病质。与ω-3联合治疗可改善体重增加、心脏射血分数、左室收缩期缩短、心脏标志物CK-MB 和肌钙蛋白I水平、左心室面积及组织病理学参数(炎症、水肿、细胞损伤和肌肉纤维)指标,表明具有保护作用。此外,ω-3展示了抗基因毒性活性,通过减少微核的数量得以证明。这些发现表明,ω-3可作为化疗的有效补充,减轻多柔比星的毒性。

    关键词: 心脏毒性;化疗;血液学参数。

    关键词:omega-3; 多柔比星; 毒性; 临床前试验

    翻译效果不满意? 用Ai改进或 寻求AI助手帮助 ,对摘要进行重点提炼
    Copyright © Toxicology reports. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Toxicology reports

    缩写:

    ISSN:2214-7500

    e-ISSN:

    IF/分区:0.0/

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Protective effect of omega-3 on reducing doxorubicin toxicity in preclinical trials